再鼎医药宣布2.5亿美元私募配售（ZLAB:NASDAQ）
· seekingalpha.com
再鼎医药通过PIPE融资筹集2.5亿美元，以推进其靶向DLL3的ADC药物zoci。
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...